Author Topic: (Abst.) Disease-modifying drugs for MS and association with survival  (Read 14 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9542
  • MS diagnosed 1980
  • Location: Pacific Northwest

Two of the authors listed for this study, Helen Tremlett and Ruth Ann Marrie, have been contributing to MS research for quite a number of years.

From PubMed (June 15, 2022)--"Disease-modifying drugs for multiple sclerosis and association with survival":


https://pubmed.ncbi.nlm.nih.gov/35701187/
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
93 Views
Last post May 16, 2017, 11:42:43 am
by agate
0 Replies
93 Views
Last post June 01, 2017, 02:12:21 pm
by agate
0 Replies
70 Views
Last post December 13, 2017, 02:44:44 pm
by agate
0 Replies
42 Views
Last post July 12, 2021, 02:30:05 pm
by agate
0 Replies
35 Views
Last post July 12, 2021, 02:33:26 pm
by agate